vs

Side-by-side financial comparison of Strategy Inc (MSTR) and Organogenesis Holdings Inc. (ORGO). Click either name above to swap in a different company.

Organogenesis Holdings Inc. is the larger business by last-quarter revenue ($225.6M vs $123.0M, roughly 1.8× Strategy Inc). On growth, Organogenesis Holdings Inc. posted the faster year-over-year revenue change (78.1% vs 1.9%). Over the past eight quarters, Organogenesis Holdings Inc.'s revenue compounded faster (43.2% CAGR vs 3.3%).

Strategy Inc., formerly known as MicroStrategy, is an American company that provides business intelligence (BI) and mobile software. Founded in 1989 by Michael J. Saylor, Sanju Bansal, and Thomas Spahr, the firm develops software to analyze internal and external data in order to make business decisions and to develop mobile apps. It is a public company headquartered in Tysons Corner, Virginia, in the Washington metropolitan area. Its primary business analytics competitors include SAP SE Busin...

Organogenesis Holdings Inc. is a leading regenerative medicine firm specializing in developing and manufacturing advanced therapeutic products for wound care, surgical repair, sports medicine, and dermatology. It serves healthcare providers and patients primarily in the U.S. and select international markets, offering clinically validated solutions for unmet medical needs.

MSTR vs ORGO — Head-to-Head

Bigger by revenue
ORGO
ORGO
1.8× larger
ORGO
$225.6M
$123.0M
MSTR
Growing faster (revenue YoY)
ORGO
ORGO
+76.2% gap
ORGO
78.1%
1.9%
MSTR
Faster 2-yr revenue CAGR
ORGO
ORGO
Annualised
ORGO
43.2%
3.3%
MSTR

Income Statement — Q2 FY2026 vs Q4 FY2025

Metric
MSTR
MSTR
ORGO
ORGO
Revenue
$123.0M
$225.6M
Net Profit
$43.7M
Gross Margin
66.1%
Operating Margin
28.1%
Net Margin
19.4%
Revenue YoY
1.9%
78.1%
Net Profit YoY
469.5%
EPS (diluted)
$0.31

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
MSTR
MSTR
ORGO
ORGO
Q4 25
$123.0M
$225.6M
Q3 25
$128.7M
$150.9M
Q2 25
$114.5M
$101.0M
Q1 25
$111.1M
$86.7M
Q4 24
$120.7M
$126.7M
Q3 24
$116.1M
$115.2M
Q2 24
$111.4M
$130.2M
Q1 24
$115.2M
$110.0M
Net Profit
MSTR
MSTR
ORGO
ORGO
Q4 25
$43.7M
Q3 25
$2.8B
$21.6M
Q2 25
$10.0B
$-9.4M
Q1 25
$-4.2B
$-18.8M
Q4 24
$-670.8M
$7.7M
Q3 24
$-340.2M
$12.3M
Q2 24
$-102.6M
$-17.0M
Q1 24
$-53.1M
$-2.1M
Gross Margin
MSTR
MSTR
ORGO
ORGO
Q4 25
66.1%
Q3 25
70.5%
Q2 25
68.8%
Q1 25
69.4%
72.6%
Q4 24
71.7%
75.5%
Q3 24
70.4%
76.7%
Q2 24
72.2%
77.6%
Q1 24
74.0%
73.9%
Operating Margin
MSTR
MSTR
ORGO
ORGO
Q4 25
28.1%
Q3 25
13.7%
Q2 25
-12.5%
Q1 25
-5331.4%
-30.9%
Q4 24
-842.1%
8.1%
Q3 24
-372.7%
5.4%
Q2 24
-179.7%
-10.7%
Q1 24
-176.8%
-3.5%
Net Margin
MSTR
MSTR
ORGO
ORGO
Q4 25
19.4%
Q3 25
2164.1%
14.3%
Q2 25
8752.7%
-9.3%
Q1 25
-3797.2%
-21.7%
Q4 24
-555.8%
6.1%
Q3 24
-293.1%
10.7%
Q2 24
-92.0%
-13.1%
Q1 24
-46.1%
-1.9%
EPS (diluted)
MSTR
MSTR
ORGO
ORGO
Q4 25
$0.31
Q3 25
$8.42
$0.11
Q2 25
$32.60
$-0.10
Q1 25
$-16.49
$-0.17
Q4 24
$4.49
$0.05
Q3 24
$-1.72
$0.09
Q2 24
$-0.57
$-0.13
Q1 24
$-0.31
$-0.02

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
MSTR
MSTR
ORGO
ORGO
Cash + ST InvestmentsLiquidity on hand
$2.3B
$93.7M
Total DebtLower is stronger
$8.2B
Stockholders' EquityBook value
$44.1B
$300.1M
Total Assets
$61.6B
$598.7M
Debt / EquityLower = less leverage
0.19×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
MSTR
MSTR
ORGO
ORGO
Q4 25
$2.3B
$93.7M
Q3 25
$54.3M
$63.7M
Q2 25
$50.1M
$73.1M
Q1 25
$60.3M
$110.0M
Q4 24
$38.1M
$135.6M
Q3 24
$46.3M
$94.3M
Q2 24
$66.9M
$89.9M
Q1 24
$81.3M
$88.6M
Total Debt
MSTR
MSTR
ORGO
ORGO
Q4 25
$8.2B
Q3 25
$8.2B
Q2 25
$8.2B
Q1 25
$8.1B
Q4 24
$7.2B
Q3 24
$4.2B
$62.3M
Q2 24
$3.8B
$63.8M
Q1 24
$3.6B
$65.2M
Stockholders' Equity
MSTR
MSTR
ORGO
ORGO
Q4 25
$44.1B
$300.1M
Q3 25
$52.3B
$255.1M
Q2 25
$47.5B
$233.2M
Q1 25
$32.2B
$242.9M
Q4 24
$18.2B
$262.9M
Q3 24
$3.8B
$278.5M
Q2 24
$2.8B
$263.5M
Q1 24
$2.4B
$278.0M
Total Assets
MSTR
MSTR
ORGO
ORGO
Q4 25
$61.6B
$598.7M
Q3 25
$73.6B
$509.8M
Q2 25
$64.8B
$461.1M
Q1 25
$43.9B
$467.4M
Q4 24
$25.8B
$497.9M
Q3 24
$8.3B
$446.3M
Q2 24
$7.1B
$443.2M
Q1 24
$6.4B
$458.5M
Debt / Equity
MSTR
MSTR
ORGO
ORGO
Q4 25
0.19×
Q3 25
0.16×
Q2 25
0.17×
Q1 25
0.25×
Q4 24
0.39×
Q3 24
1.12×
0.22×
Q2 24
1.36×
0.24×
Q1 24
1.48×
0.23×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
MSTR
MSTR
ORGO
ORGO
Operating Cash FlowLast quarter
$39.4M
Free Cash FlowOCF − Capex
$34.8M
FCF MarginFCF / Revenue
15.4%
Capex IntensityCapex / Revenue
2.1%
Cash ConversionOCF / Net Profit
0.90×
TTM Free Cash FlowTrailing 4 quarters
$-24.5M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
MSTR
MSTR
ORGO
ORGO
Q4 25
$39.4M
Q3 25
$-8.3M
$3.1M
Q2 25
$-34.9M
$-32.9M
Q1 25
$-2.4M
$-19.9M
Q4 24
$-17.3M
$10.9M
Q3 24
$-41.0M
$8.7M
Q2 24
$-23.3M
$4.7M
Q1 24
$28.6M
$-10.2M
Free Cash Flow
MSTR
MSTR
ORGO
ORGO
Q4 25
$34.8M
Q3 25
$-11.1M
$844.0K
Q2 25
$-37.0M
$-36.5M
Q1 25
$-5.1M
$-23.6M
Q4 24
$-17.6M
$7.6M
Q3 24
$-41.4M
$6.1M
Q2 24
$-24.1M
$2.9M
Q1 24
$27.0M
$-12.4M
FCF Margin
MSTR
MSTR
ORGO
ORGO
Q4 25
15.4%
Q3 25
-8.6%
0.6%
Q2 25
-32.3%
-36.1%
Q1 25
-4.6%
-27.2%
Q4 24
-14.6%
6.0%
Q3 24
-35.7%
5.3%
Q2 24
-21.6%
2.2%
Q1 24
23.5%
-11.3%
Capex Intensity
MSTR
MSTR
ORGO
ORGO
Q4 25
2.1%
Q3 25
2.2%
1.5%
Q2 25
1.8%
3.6%
Q1 25
2.5%
4.2%
Q4 24
0.2%
2.7%
Q3 24
0.4%
2.2%
Q2 24
0.6%
1.4%
Q1 24
1.3%
2.0%
Cash Conversion
MSTR
MSTR
ORGO
ORGO
Q4 25
0.90×
Q3 25
-0.00×
0.14×
Q2 25
-0.00×
Q1 25
Q4 24
1.43×
Q3 24
0.71×
Q2 24
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons